Principal International Equity ETF (PIEQ)
Live price chart, market sentiment, and community perspectives for Principal International Equity ETF (CBOE: PIEQ).
Live price chart, market sentiment, and community perspectives for Principal International Equity ETF (CBOE: PIEQ).
On our desk, we are tracking the sharp contraction in PIEQ short interest, which plunged by 53.4% down to just 17,835 shares by mid-July. With a tiny short interest ratio of 0.5 days and only 0.1% of shares shorted, selling pressure has evaporated entirely. This technical backdrop reinforces the bullish price action we've monitored since the fund's November 2024 launch, making it a compelling candidate for unconstrained international equity exposure.
As a risk manager reviewing the portfolio characteristics, I am struck by the extreme concentration of PIEQ. While a typical broad benchmark holds nearly two thousand stocks, PIEQ keeps a tight basket of just 35 holdings with an active share of 85.2%. This concentration produces impressive fundamentals, such as a projected earnings growth of 22.0% versus the benchmark's 15.7%, but it also demands strict monitoring of individual stock-level volatility.
When evaluating active equity managers for our quantitative allocations, PIEQ stands out due to its unique process. The strategy focuses on free cash flow power that the market underestimates, blending both growth and value simultaneously across developed and emerging markets. The management team—led by veterans like George P. Maris, Matt Peron, and Paul Blankenhagen—brings decades of experience that justifies the 0.48% expense ratio.
Watching the institutional capital flows in Q2 2026, it's clear that smart money is embracing PIEQ. Regulatory filings show 26 hedge funds and large institutions holding $1.68B, with 9 new positions opened and 10 increased against only 3 closed. Total fund ownership spiked by 18% to reach 125.63%. This level of institutional sponsorship validates the top-ranked Foreign Large Blend status on Seeking Alpha's Quant system.
From our quantitative analytics perspective, PIEQ's valuation profile looks notably attractive against broader foreign benchmarks. The fund's forward price-to-earnings ratio sits at 13.0x compared to the broader index at 16.6x, while its return on equity stands solid at 15.7%. Despite facing a volatile second quarter defined by narrow markets and momentum-driven AI sentiment, the fund's adherence to deep fundamental analysis has cushioned its trajectory.
Explore plasma cleansing, somatic organ swaps, and BCI.